The mortality for open procedures for VEs has also decreased, suggesting improvements in perioperative care. There was, unexpectedly, an increase in mortality for rTAA, suggesting greater utilization of endovascular therapy for high-risk patients who previously may not have been candidates for repair. Further studies evaluating the selection of patients for endovascular repair of rTAA are warranted as mortality increased over time coupled with an increased hospital cost. Pregnancy induces a transient hypercoagulable state, increasing the risk for venous thromboembolism. Early thrombus removal over anticoagulation alone reduces post-thrombotic syndrome, especially in those with acute iliofemoral deep venous thrombosis (DVT). However, pregnancy is a relative contraindication because of radiation exposure of the fetus and increased risk of bleeding with tissue plasminogen activator (tPA). This case report demonstrates successful treatment of acute iliofemoral DVT in a pregnant woman using intravascular ultrasound (IVUS)-guided catheter thrombectomy without fluoroscopy or tPA.
Pregnancy induces a transient hypercoagulable state, increasing the risk for venous thromboembolism. Early thrombus removal over anticoagulation alone reduces post-thrombotic syndrome, especially in those with acute iliofemoral deep venous thrombosis (DVT). However, pregnancy is a relative contraindication because of radiation exposure of the fetus and increased risk of bleeding with tissue plasminogen activator (tPA). This case report demonstrates successful treatment of acute iliofemoral DVT in a pregnant woman using intravascular ultrasound (IVUS)-guided catheter thrombectomy without fluoroscopy or tPA.
A 29-year-old healthy woman who is 10 weeks pregnant presented to the emergency department with left leg pain, swelling, and difficulty in walking. Duplex ultrasound demonstrated acute DVT of the left external iliac, common femoral, proximal profundal femoral, femoral, popliteal, gastric, peroneal, posterior tibial, and soleal veins. The contralateral venous system was patent. Arterial study findings were also normal. She was immediately anticoagulated with therapeutic enoxaparin.
The patient and husband agreed to undergo early endovascular thrombus removal. In the prone position, the left popliteal vein was percutaneously accessed. IVUS confirmed complete occlusion of the left femoropopliteal vein and external and common iliac vein. IVUS was also used to measure the length of catheter needed to traverse the extensive DVT. Thrombectomy by an AngioJet Omni Solent catheter (Boston Scientific, Marlborough, Mass) was performed for 2 minutes using the predetermined catheter length with no tPA. Completion IVUS demonstrated successful revascularization with 50% resolution of thrombus burden.
The patient was discharged home with therapeutic enoxaparin and compression stockings. Hypercoagulability workup demonstrated decreased protein S activity (<20%) and positive factor V Leiden heterozygous mutation for the 1691G>A. At 4 weeks postoperatively, the patient had no swelling or pain in her legs. Duplex ultrasound demonstrated complete resolution of her extensive DVT. The birth of her healthy child was uncomplicated. Her postpartum protein S activity normalized, and postpartum duplex ultrasound examination also showed no evidence of recurrent DVT. She continued enoxaparin until 6 weeks post partum and remained asymptomatic for 3 years.
Endovascular early thrombus removal can be performed safely and successfully during pregnancy using IVUS without fluoroscopy and catheter-directed mechanical thrombectomy without tPA.
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Results of Carotid Endarterectomy in Patients
Results: Patients with cICAoccl were younger; they more likely to be smokers and to have chronic obstructive pulmonary disease, preoperative neurologic symptoms (56% vs 47%), nonelective CEA (16% vs 13%), and shunt placement (75% vs 53%; all P < .001). The 30-day ipsilateral stroke risk was 1.3% with vs 0.7% without cICAoccl (P ¼ .004). The 30-day and 1-year survival estimates were 99.0% 6 0.5% and 94.1% 6 1.1% with vs 99.6% 6 0.1% and 96.0% 6 0.2% without cICAoccl (log-rank, P < .001). Logistic regression analysis identified prior neurologic event (P ¼ .046), nonelective surgery (P ¼ .047), and preoperative angiotensin-converting enzyme inhibitor use (P ¼ .029) to be associated with 30-day ipsilateral stroke risk, but cICAoccl remained an independent predictor in that model (odds ratio, 2.29; P ¼ .026). However, after adjustment for other factors (Cox proportional hazards), risk of ipsilateral stroke (including perioperative) during follow-up was not significantly greater with cICAoccl (hazard ratio, 1.21; P ¼ .32).
Conclusions: cICAoccl was associated with greater risk of perioperative ipsilateral stroke even after adjustment for other variables. However, after adjustment for other variables, cICAoccl was not associated with a greater risk of ipsilateral stroke (including perioperative) in longer follow-up. Mortality was greater with cICAoccl, and this difference was more pronounced at 1 year despite younger age of the cICAoccl group. Although ipsilateral stroke risk is greater for cICAoccl, risk remains low and appears to be explained in part by other factors, and the difference may be clinically insignificant. CEA may be considered appropriate despite cICAoccl.
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